It is thought that CD38-expressing cells contribute to disease ... in the kidneys and cause inflammation and loss of kidney function. Felzartamab's mode of action is to deplete those antibody ...

Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...

HUTCHMED provides full year 2025 guidance for Oncology/Immunology consolidated revenue of $350 million to $450 million. HUTCHMED's work in 2025 and beyond will be supported by its strong balance sheet ...

Out of six evaluable patients on that dose, four achieved remission and stable kidney function. A higher 240 mg dose achieved similar results. Vertex’s move for Alpine marks a turnaround in the ...

Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States Department of Immunology, Department of ...